CSL Limited (OTCMKTS:CSLLY) Short Interest Up 208.3% in July

CSL Limited (OTCMKTS:CSLLY) was the target of a significant increase in short interest in the month of July. As of July 31st, there was short interest totalling 3,700 shares, an increase of 208.3% from the July 15th total of 1,200 shares. Based on an average trading volume of 37,100 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

Separately, Macquarie raised CSL to a “strong-buy” rating in a report on Tuesday.

CSL Price Performance

OTCMKTS:CSLLY opened at $99.88 on Thursday. The business’s 50-day simple moving average is $99.62 and its two-hundred day simple moving average is $95.19. CSL has a 52 week low of $71.51 and a 52 week high of $106.82.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.